Lazard Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.7M | Buy |
|
|||||
|
2025
Q1 | $23M | Buy |
|
|||||
|
2024
Q4 | $14.7M | Sell |
|
|||||
|
2024
Q3 | $24.4M | Sell |
|
|||||
|
2024
Q2 | $72.1M | Sell |
|
|||||
|
2024
Q1 | $74M | Buy |
|
|||||
|
2023
Q4 | $60M | Buy |
|
|||||
|
2023
Q3 | $54.9M | Buy |
|
|||||
|
2023
Q2 | $43.7M | Sell |
|
|||||
|
2023
Q1 | $45.7M | Sell |
|
|||||
|
2022
Q4 | $53M | Sell |
|
|||||
|
2022
Q3 | $76.5M | Sell |
|
|||||
|
2022
Q2 | $86.3M | Sell |
|
|||||
|
2022
Q1 | $91M | Sell |
|
|||||
|
2021
Q4 | $86.9M | Sell |
|
|||||
|
2021
Q3 | $80.6M | Sell |
|
|||||
|
2021
Q2 | $86.4M | Buy |
|
|||||
|
2021
Q1 | $75.3M | Buy |
|
|||||
|
2020
Q4 | $50.8M | Sell |
|
|||||
|
2020
Q3 | $58.1M | Buy |
|
|||||
|
2020
Q2 | $41.7M | Sell |
|
|||||
|
2020
Q1 | $153M | Sell |
|
|||||
|
2019
Q4 | $254M | Buy |
|
|||||
|
2019
Q3 | $153M | Sell |
|
|||||
|
2019
Q2 | $225M | Buy |
|
|||||
|
2019
Q1 | $35.1M | Sell |
|
|||||
|
2018
Q4 | $48.5M | Sell |
|
|||||
|
2018
Q3 | $54.9M | Buy |
|
|||||
|
2018
Q2 | $39.5M | Buy |
|
|||||
|
2018
Q1 | $35.7M | Buy |
|
|||||
|
2017
Q4 | $36.3M | Buy |
|
|||||
|
2017
Q3 | $20M | Buy |
|
|||||
|
2017
Q2 | $8.64M | Sell |
|
|||||
|
2017
Q1 | $7.68M | Sell |
|
|||||
|
2016
Q4 | $6.79M | Sell |
|
|||||
|
2016
Q3 | $6.1M | Sell |
|
|||||
|
2016
Q2 | $6.68M | Buy |
|
|||||
|
2016
Q1 | $7.06M | Buy |
|
|||||
|
2015
Q4 | $6.08M | Buy |
|
|||||
|
2015
Q3 | $4.52M | Buy |
|
|||||
|
2015
Q2 | $4K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $3.01M | Buy |
|